Several inflammatory biomarkers, including high sensitivity C-reactive protein (CRP) [23], soluble adhesion molecules (such as sICAM [24]), and tumor necrosis factor-α (TNF-α) [25], are associated with both the incidence and severity of PAD [26]. This evidence concerns the gene CRP and peripheral arterial disease.